Browse Guides  internal medicine  pulmonology

Exacerbation of Chronic Obstructive Pulmonary Disease

Prevalence
Clinical features
Differential Diagnosis
Investigations
Therapy
Prevention
Prognosis
Therapy

Consider non-invasive ventilation a b for patients with respiratory failure: a
  • tachypnoea: rate 23 per minute or more
  • pH 7.25 to 7.35 with pCO2 > 6 kPa

Why?

  • Non-invasive positive pressure ventilation reduces need for endotracheal intubation and death a b and helps reduce days on mechanical ventilation if used as an adjunct to weaning (on average 6 days) a
  • However complications are common. These include facial skin abrasions or necrosis (2.1% to 21%), pneumonia (0.6% to 5.5%), retention of secretions (0% to 17%), conjunctivitis (0% to 14%), and gastric distention (0% to 3%). a
  • Facial masks are better tolerated than nasal masks. They cause more facial necrosis and gastric distention, but less conjunctivitis than nasal masks. a
  • Ventillatory support and aggressive care is poorly cost-effective for high-risk patients (> 50% chance of dying within 2 months)  with acute respiratory failure. a

Non-invasive ventilation reduces intubation and death in severe cases

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
acute exacerbation of COPD b non-invasive ventilation no ventilation required endotracheal intubation
74% 65%
(40% to 80%)
2
(1 to 3)
      death
at weeks
26% 67%
(7% to 89%)
5
(3 to 32)
COPD on mechanical ventilation a non-invasive ventilation weaning standard weaning failure to wean 52% 69%
(19% to 88%)
3
(2 to 9)

 

Expiry date: July 2003
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   N R   Anthonisen
CAT Writers   B   Phillips , CJ   Wotton , CM   Ball